RPL10 (ribosomal protein L10)

2010-08-01   Mohit Goel , Ranjan Tamuli 

Department of Biotechnology, Indian Institute of Technology Guwahati, Guwahati-781 039, Assam, India

Identity

HGNC
LOCATION
Xq28
LOCUSID
ALIAS
DKFZp686J1851,DXS648,DXS648E,FLJ23544,FLJ27072,NOV,QM
FUSION GENES

DNA/RNA

Atlas Image

Description

DNA size 3.96 kb, mRNA size 2172 bp, 7 exons. The RPL10 gene is co-transcribed with the small nucleolar RNA gene U70 that is located in its fifth intron. Multiple processed pseudogenes of the gene RPL10 are dispersed in the genome. Moreover, transcript variants utilizing alternative polyA signals exist; the variant with the longest 3 UTR overlaps the deoxyribonuclease I-like 1 gene on the opposite strand.

Proteins

Expression

Ubiquitous. RPL10 is expressed in a wide variety of embryonic and adult tissues, down-regulated during adipocyte, kidney, and heart differentiation.

Localisation

Cytoplasm.

Function

The ribosomal protein L10 (RPL10), a member of the L10E family of ribosomal proteins, is a key protein in assembling 60S ribosomal subunit and organizes the architecture of the aminoacyl-tRNA binding site. RPL10 was originally identified as QM, a candidate for a Wilms tumor suppressor; however, later studies did not support the original hypothesis. In vitro studies have shown the interaction of RPL10 with the transcript regulator the c-Jun, as well as with the proto-oncogene c-Yes; however, these interactions yet to demonstrate in vivo.

Homology

The percent identity below represents identity of RPL10 over an aligned region in UniGene.
- Mus musculus: 100 (percent identity)
- Xenopus tropicalis: 99.5
- Monodelphis domestica: 99.5
- Pan troglodytes: 99.5
- Xenopus laevis: 99.1
- Danio rerio: 97.7
- Drosophila melanogaster: 88.9
- Caenorhabditis elegans: 85.5
- Neurospora crassa: 84.7
- Saccharomyces cerevisiae: 78.3

Mutations

Note

Two missense mutations L206M and H213Q at the C-terminal end of RPL10 were identified in two independent families with autism, a disorder of neural development.

Implicated in

Entity name
Prostatic adenocarcinoma
Note
RPL10 gene showed up-regulation in androgen-independent C81 passage cells, derived from the LNCaP cell model that recapitulates prostate cancer progression. In a study using immunohistochemical technique, human prostatic tissues showed expression of RPL10 protein in all normal prostate glands adjacent to prostate cancer and in various intraepithelial neoplasia (PIN). However, in prostate cancer, the staining intensity and stained areas were decreased, compared to the normal glands and PIN lesions. There was an inverse correlation from normal to low-grade tumors and then to high-grade tumors. In high-grade tumors, the positive areas were mostly confined to peripheral aspects of tumors and were particularly strong in foci of perineural invasion. These results suggested that decreased RPL10 expression may be associated with early development of prostate cancer, but later a high level of RPL10 may facilitate progression of the tumors to a more aggressive phenotype.
Entity name
Ovarian cancer
Note
Both adenine (A)/guanine (G) replacement was detected at the 605th nucleotide which changes the coding from serine to asparagines in 17 (58.6%) of the 29 ovarian tumors studied. The frequencies of A/A, G/G and A/G homo- or hetero-zygosity were 3.5%, 37.9% and 58.6%, respectively in cancer tissues but they were 26.1%, 52.2% and 21.7%, respectively in the adjacent normal tissues, indicating a higher heterozygous rate in cancer (58.6% vs 21.7%, p
Entity name
Wilms tumor
Note
RPL10 was originally isolated by subtractive hybridization between a tumorigenic cell line (deleted for part of 11p) and a non-tumorigenic cell line (the tumorigenic cell line carrying an extra t(X;11) translocation chromosome). The RPL10 mRNA level was found modulated between the tumorigenic and nontumorigenic cell lines and suspected to be involved in the maintenance of the nontumorigenic phenotype. However, later study had shown that the RPL10 gene is X-linked and therefore not involved in suppression of tumorigenesis in Wilms tumor.

Bibliography

Pubmed IDLast YearTitleAuthors
163312982006Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.Altinok G et al
16587431991The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic Wilms' microcell hybrid cells.Dowdy SF et al
191665812009An investigation of ribosomal protein L10 gene in autism spectrum disorders.Gong X et al
120820182002Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells.Karan D et al
169409772006Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism.Klauck SM et al
166279772006Loss of heterozygosity and microsatellite instability at the Xq28 and the A/G heterozygosity of the QM gene are associated with ovarian cancer.Shen XJ et al
13308781992The QM gene is X-linked and therefore not involved in suppression of tumorigenesis in Wilms' tumor.van den Ouweland AM et al

Other Information

Locus ID:

NCBI: 6134
MIM: 312173
HGNC: 10298
Ensembl: ENSG00000147403

Variants:

dbSNP: 6134
ClinVar: 6134
TCGA: ENSG00000147403
COSMIC: RPL10

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000147403ENST00000344746P27635
ENSG00000147403ENST00000344746X5D2T3
ENSG00000147403ENST00000369817P27635
ENSG00000147403ENST00000369817X5D2T3
ENSG00000147403ENST00000406022F8W7C6
ENSG00000147403ENST00000424325P27635
ENSG00000147403ENST00000424325X5D2T3
ENSG00000147403ENST00000427682H7C2C5
ENSG00000147403ENST00000428169H7C123
ENSG00000147403ENST00000436473X1WI28
ENSG00000147403ENST00000449494H7C2U2
ENSG00000147403ENST00000451365B8A6G2
ENSG00000147403ENST00000458500A6QRI9
ENSG00000147403ENST00000618723A0A087WV22

Expression (GTEx)

0
1000
2000
3000
4000
5000
6000

Pathways

PathwaySourceExternal ID
RibosomeKEGGko03010
RibosomeKEGGhsa03010
Ribosome, eukaryotesKEGGhsa_M00177
Ribosome, eukaryotesKEGGM00177
Metabolism of proteinsREACTOMER-HSA-392499
TranslationREACTOMER-HSA-72766
Eukaryotic Translation InitiationREACTOMER-HSA-72613
Cap-dependent Translation InitiationREACTOMER-HSA-72737
Formation of a pool of free 40S subunitsREACTOMER-HSA-72689
GTP hydrolysis and joining of the 60S ribosomal subunitREACTOMER-HSA-72706
L13a-mediated translational silencing of Ceruloplasmin expressionREACTOMER-HSA-156827
SRP-dependent cotranslational protein targeting to membraneREACTOMER-HSA-1799339
Eukaryotic Translation ElongationREACTOMER-HSA-156842
Peptide chain elongationREACTOMER-HSA-156902
Eukaryotic Translation TerminationREACTOMER-HSA-72764
DiseaseREACTOMER-HSA-1643685
Infectious diseaseREACTOMER-HSA-5663205
Influenza InfectionREACTOMER-HSA-168254
Influenza Life CycleREACTOMER-HSA-168255
Influenza Viral RNA Transcription and ReplicationREACTOMER-HSA-168273
Viral mRNA TranslationREACTOMER-HSA-192823
Gene ExpressionREACTOMER-HSA-74160
Nonsense-Mediated Decay (NMD)REACTOMER-HSA-927802
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)REACTOMER-HSA-975957
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)REACTOMER-HSA-975956
MetabolismREACTOMER-HSA-1430728
Metabolism of amino acids and derivativesREACTOMER-HSA-71291
Selenoamino acid metabolismREACTOMER-HSA-2408522
Selenocysteine synthesisREACTOMER-HSA-2408557
rRNA processingREACTOMER-HSA-72312
Major pathway of rRNA processing in the nucleolus and cytosolREACTOMER-HSA-6791226
rRNA processing in the nucleus and cytosolREACTOMER-HSA-8868773

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
232634912013Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia.153
199131212009Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.85
253167882014A novel ribosomopathy caused by dysfunction of RPL10 disrupts neurodevelopment and causes X-linked microcephaly in humans.33
169409772006Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism.31
287440132018The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling.14
215679172011Mutation and expression analyses of the ribosomal protein gene RPL10 in an extended German sample of patients with autism spectrum disorder.13
206280862010Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.11
277264202016Mitochondrial Ribosomal Protein L10 Associates with Cyclin B1/Cdk1 Activity and Mitochondrial Function.10
299303002019The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.10
121380902002QM, a putative tumor suppressor, regulates proto-oncogene c-yes.9

Citation

Mohit Goel ; Ranjan Tamuli

RPL10 (ribosomal protein L10)

Atlas Genet Cytogenet Oncol Haematol. 2010-08-01

Online version: http://atlasgeneticsoncology.org/gene/42148/rpl10